| Glaxosmithkline Share Price | |||
|---|---|---|---|
| Price | 1,924.50 | Open | 1,925.00 |
| Bid | 1,925.50 | High | 1,931.50 |
| Ask | 1,926.50 | Low | 1,912.00 |
| Change | -1.00 (-0.05%) | Close | 1,925.50 |
| Volume | 3,565,700 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 4.01b |
| Market Cap | £77.13b |
| PE Ratio | 13.63926 |
| EPS | 141.10 |
| Year High | 2,282.00 |
|---|---|
| Year High Date | 18-Feb-2026 |
| Year Low | 1,315.00 |
| Year Low Date | 18-Jul-2025 |
| Dividend | 63.00 |
| Yield | 3.274% |
| # Trades | 12,282 |
|---|---|
| Vol. Sold | 2,327,792 |
| Sold Value | £44.74m |
| Vol. Bought | 702,022 |
| Bought Value | £13.48m |
| Market Size | 1,000 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 22-Jun-26 | 17:49:55 | 1,915.00 | 250,000 | Unknown* | 1,925.50 | 1,926.50 | 5m | O Ordinary Was reported as OTC |
| 22-Jun-26 | 16:47:12 | 1,924.50 | 3,045 | Unknown* | 1,925.50 | 1,926.50 | 58.60k | O Ordinary Was reported as OTC |
| 22-Jun-26 | 16:17:42 | 1,924.38453 | 1,100 | Unknown* | 1,925.50 | 1,926.50 | 21.17k | O Ordinary Delayed publication Trade was executed as an SI |
| 22-Jun-26 | 16:17:42 | 0.00 | -1,100 | Unknown* | 1,925.50 | 1,926.50 | 0.00 | O Ordinary Deletion Delayed publication Trade was executed as an SI |
| 22-Jun-26 | 10:04:40 | 1,924.50 | 5,410 | Unknown* | 1,925.50 | 1,926.50 | 104.12k | O Ordinary Delayed publication Trade was executed as an SI |
| 22-Jun-26 | 10:04:40 | 0.00 | -5,410 | Unknown* | 1,925.50 | 1,926.50 | 0.00 | O Ordinary Deletion Delayed publication Trade was executed as an SI |
| 22-Jun-26 | 16:36:11 | 1,924.50 | 12 | Sell* | 1,925.50 | 1,926.50 | 230.94 | A Automatic Execution |
| 22-Jun-26 | 16:35:18 | 1,924.50 | 171 | Sell* | 1,925.50 | 1,926.50 | 3,291 | A Automatic Execution |
| 22-Jun-26 | 16:35:18 | 1,924.50 | 29 | Sell* | 1,925.50 | 1,926.50 | 558.11 | A Automatic Execution |
| 22-Jun-26 | 16:35:18 | 1,924.50 | 10 | Sell* | 1,925.50 | 1,926.50 | 192.45 | A Automatic Execution |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 11-Jun-26 | 10-Jun-26 | Transfer From | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 0.00 | 7 | 44,506 | |
| 11-Jun-26 | 09-Jun-26 | Buy | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 1,883.93 | GBX | 7 | 44,506 |
| 20-May-26 | 15-May-26 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 74 | 15,323,778 |
| 19-May-26 | 15-May-26 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 2,301 | 15,323,704 |
| 14-May-26 | 12-May-26 | Transfer From | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 0.00 | 7 | 44,492 |
At GSK, we unite science, technology and talent to get ahead of disease together